» Authors » Andrew E Blum

Andrew E Blum

Explore the profile of Andrew E Blum including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 175
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Greer K, Blum A, Faulx A, Deming E, Hricik L, Siddiqui H, et al.
Am J Gastroenterol . 2024 Jul; 120(3):545-553. PMID: 38989889
Introduction: Although rates of esophageal adenocarcinoma (EAC) in the United States continue to rise, many patients at risk of disease are not screened. EsoCheck (EC), a nonendoscopic esophageal balloon sampling...
2.
Ravillah D, Kieber-Emmons A, Singh S, Keerthy K, Blum A, Guda K
Gastroenterology . 2023 May; 165(2):505-508.e7. PMID: 37182784
No abstract available.
3.
Blum A, Ravillah D, Katabathula R, Khalighi S, Varadan V, Guda K
Gastroenterology . 2022 Aug; 163(5):1457-1460. PMID: 35934060
No abstract available.
4.
Venkitachalam S, Babu D, Ravillah D, Katabathula R, Joseph P, Singh S, et al.
Gastroenterology . 2022 Jul; 163(5):1228-1241. PMID: 35870513
Background & Aims: Mechanisms contributing to the onset and progression of Barrett's (BE)-associated esophageal adenocarcinoma (EAC) remain elusive. Here, we interrogated the major signaling pathways deregulated early in the development...
5.
Glamour B, Alaber O, Cioffi G, Chandar A, Barnholtz-Sloan J, Brock W, et al.
Fam Cancer . 2021 Mar; 21(1):115-120. PMID: 33694069
The identification of hereditary cancer genes for esophageal adenocarcinoma (EAC) and its precursor, Barrett's esophagus (BE), may prove critical for the development of novel prevention and treatment strategies. Specifically, efforts...
6.
Blum A, Venkitachalam S, Ravillah D, Chelluboyina A, Kieber-Emmons A, Ravi L, et al.
Gastroenterology . 2019 Feb; 156(6):1761-1774. PMID: 30768984
Background & Aims: Esophageal adenocarcinoma (EAC) is resistant to standard chemoradiation treatments, and few targeted therapies are available. We used large-scale tissue profiling and pharmacogenetic analyses to identify deregulated signaling...
7.
Blum A, Venkitachalam S, Guo Y, Kieber-Emmons A, Ravi L, Chandar A, et al.
Cancer Res . 2016 Aug; 76(19):5628-5633. PMID: 27503924
Esophageal adenocarcinoma is a deadly cancer with increasing incidence in the United States, but mechanisms underlying pathogenesis are still mostly elusive. In addressing this question, we assessed gene fusion landscapes...
8.
Blum A, Hatter A, Honda K, Lu K
J Am Acad Dermatol . 2011 Jun; 65(1):e25-6. PMID: 21679804
No abstract available.
9.
Blum A, Walsh B, Dubyak G
Am J Physiol Cell Physiol . 2009 Nov; 298(2):C386-96. PMID: 19907018
We previously reported that ATP release from 1321N1 human astrocytoma cells could be stimulated either by activation of G protein-coupled receptors (GPCR) or by hypotonic stress. Cheema et al. (Cheema...
10.
Blum A, Joseph S, Przybylski R, Dubyak G
Am J Physiol Cell Physiol . 2008 May; 295(1):C231-41. PMID: 18495810
Previously, we reported that activation of G protein-coupled receptors (GPCR) in 1321N1 human astrocytoma cells elicits a rapid release of ATP that is partially dependent on a G(q)/phophospholipase C (PLC)/Ca(2+)...